Are Analysts Bullish RELX PLC (NYSE:RELX) After Last Week?

April 17, 2018 - By Migdalia James

RELX PLC (NYSE:RELX) Logo

RELX PLC (NYSE:RELX) Ratings Coverage

Among 3 analysts covering RELX (NYSE:RELX), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. RELX had 3 analyst reports since January 10, 2018 according to SRatingsIntel. The stock of RELX PLC (NYSE:RELX) earned “Buy” rating by Goldman Sachs on Wednesday, January 10. The firm has “Equal-Weight” rating by Barclays Capital given on Monday, February 12. The rating was upgraded by Deutsche Bank on Friday, February 9 to “Buy”. Below is a list of RELX PLC (NYSE:RELX) latest ratings and price target changes.

12/02/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Equal-Weight Downgrade
09/02/2018 Broker: Deutsche Bank Old Rating: Hold New Rating: Buy Upgrade
10/01/2018 Broker: Goldman Sachs Old Rating: Neutral New Rating: Buy Upgrade

The stock increased 0.18% or $0.04 during the last trading session, reaching $21.91. About 184,747 shares traded. RELX PLC (NYSE:RELX) has risen 3.79% since April 17, 2017 and is uptrending. It has underperformed by 7.76% the S&P500.

RELX PLC provides information and analytics for professional and business clients in North America, Europe, and internationally. The company has market cap of $41.98 billion. The companyÂ’s Scientific, Technical & Medical segment offers information, analytics, and tools that help clients make decisions. It has a 19.09 P/E ratio. This segment provides research, reference, and education content; and database and decision tools for scientists, academic institutions, educators, research leaders and administrators, medical researchers, doctors, nurses, and allied health professionals and students, as well as hospitals, research institutions, health insurers, managed healthcare organizations, research-intensive firms, and governments.

RELX PLC (NYSE:RELX) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: